| 22.90 Delayed Data As of 4:00pm ET |  -0.97 / -4.06%Today’s Change | 7.26 Today|||52-Week Range 26.59 | +158.76% Year-to-Date |
| 3 Cancer Treatment Stocks to Buy Right Now Nov 09 / MotleyFool.com - Paid Partner Content | Iovance Biotherapeutics, Inc. (IOVA) Q3 2019 Earnings Call Transcript Nov 04 / MotleyFool.com - Paid Partner Content |
| Why Iovance Biotherapeutics Shares Are Soaring Today Nov 08 / MotleyFool.com - Paid Partner Content |
| Previous close | 23.87 |
| Today’s open | 23.86 |
| Day’s range | 22.84 - 24.19 |
| Volume | 1,359,590 |
| Average volume (3 months) | 1,286,387 |
| Market cap | $3.0B |
| Earnings growth (last year) | +9.90% |
| Earnings growth (this year) | -18.11% |
| Earnings growth (next 5 years) | -19.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.25 |
| Today’s change | Today’s % change | |
|---|---|---|
| CRSPCRISPR Therapeutics ... | +2.67 | +5.24% |
| EBSEmergent BioSolution... | +1.58 | +2.94% |
| ALLOAllogene Therapeutic... | -0.49 | -1.80% |
| IMMUImmunomedics Inc | +0.20 | +1.16% |
| Next reporting date | March 6, 2020 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$123.6M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
